Literature DB >> 12476375

[Continuous single-layer technique in turnable and nonturnable gastrointestinal anastomoses. A prospective observational study of emergency and elective operations].

M P Littke1, R Markgraf.   

Abstract

First reports about the continuous single-layer technique for gastrointestinal anastomosis have shown advantages regarding shorter time for construction and lower costs without a higher complication rate. This prospective observational study was conducted to prove the safety of routine use of the continuous single-layer technique for gastrointestinal anastomosis. All consecutive patients operated upon in the abdomino-surgical department of a community hospital in a period of 5 years with resections of the stomach, small and large bowel or upper third of the rectum were included in this study. All gastrointestinal anastomoses were performed by continuous single-layer technique using 3/0 or 4/0 absorbable PDS suture. Follow-up was until hospital discharge. 344 patients received 405 anastomoses, 30 % were emergency and 70 % elective operations. 6 anastomotic leaks (1.7 %) and 1 stenosis (0.2 %) occurred, two patients died after reoperation followed by multiple organ failure. 30-day-mortality was 12 % due to a high percentage of emergency operations, of patients with late stage malignancy, and multimorbidity or old age. The continuous single-layer technique for gastrointestinal anastomosis is safe in routine clinical practice and should receive broader attention due to its advantages.

Entities:  

Mesh:

Year:  2002        PMID: 12476375     DOI: 10.1055/s-2002-35764

Source DB:  PubMed          Journal:  Zentralbl Chir        ISSN: 0044-409X            Impact factor:   0.942


  1 in total

1.  Mid-term absorbable monofilament is safe and effective for gastrointestinal anastomosis - PROMEGAT - A single-arm prospective observational study.

Authors:  Petra Baumann; Jongwon Kim; Sang-Hoon Ahn; Hyung-Ho Kim; Hoong-Yin Chong; Moritz N Wente
Journal:  Ann Med Surg (Lond)       Date:  2018-04-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.